Arax Advisory Partners
BVS icon

Arax Advisory Partners’s Bioventus BVS Stock Holding History

Arax Advisory Partners’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$62K Buy
4,546
+191
+4% +$2.52K ﹤0.01% 3161
2026
Q2 		$41.1K Buy
4,355
+4,150
+2,024% +$39.6K ﹤0.01% 3429
2026
Q1 		$1.87K Buy
205
+106
+107% +$889 ﹤0.01% 3125
2025
Q4 		$737 Sell
99
-2,711
-96% -$19.5K ﹤0.01% 3542
2025
Q3 		$18.8K Buy
+2,810
New +$19.5K ﹤0.01% 2288
2025
Q2 		– Sell
-67
Closed -$614 – 3060
2025
Q1 		$614 Buy
67
+9
+16% +$90 ﹤0.01% 2495
2024
Q4 		$609 Buy
+58
New +$686 ﹤0.01% 2289

Other funds holding BVS

Essex Woodlands Management
Essex Woodlands Management The Woodlands, Texas $323M AUM 25.39% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Hillsdale Investment Management
Hillsdale Investment Management Toronto, Ontario, Canada $4.42B AUM 54.57% 1-Year Est. Return

Arax Advisory Partners's BVS Position: Q3 2026 in Review

Arax Advisory Partners increased its Bioventus (BVS) stake by 4.4% in Q3 2026, buying an estimated $2.52K and bringing the position to 4,546 shares worth $62K. The position accounts for ﹤0.01% of the portfolio, ranked #3161.

Arax Advisory Partners first reported a position in BVS in Q4 2024 and has held it in 7 quarters since. 127 funds tracked by Wall St. Rank hold BVS as of Q3 2026.

  • Arax Advisory Partners held 4,546 shares of Bioventus worth $62K as of Q3 2026.
  • Arax Advisory Partners bought 191 Bioventus shares in Q3 2026, an estimated $2.52K.
  • Bioventus made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #3161 holding.
  • Arax Advisory Partners first reported a position in Bioventus in Q4 2024 and has held it in 7 quarters since.
  • 127 funds tracked by Wall St. Rank held Bioventus as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.